Chronic Otitis Externa (Investigational Adjunct)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for chronic otitis externa. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.

What evidence exists?

Tier C (investigational). No controlled trials. Evidence-based first-line management is otologic examination to identify the cause (eczematous, fungal, bacterial, foreign body, underlying cholesteatoma), aural toilet, topical corticosteroid drops for inflammatory disease, topical antifungal for otomycosis, topical antibiotic-steroid combinations for bacterial disease, and identification and avoidance of triggers (water exposure, cotton swab use, hearing aids).

Main risks

• Bleeding from each bite site for 6 to 10 hours after the leech detaches
• Iron-deficiency anemia from cumulative blood loss across multiple sessions
• Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
• Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
• Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
• Local pain, bruising, swelling, or itching for 1 to 3 days after each session
• Periauricular placement near the ear canal carries bleeding and infection risks in already inflamed tissue
• Aeromonas may add a second pathogen to an already infected ear
• Bites cannot be placed inside the ear canal — that is unsafe

Who should not consider this

• Patients without ENT evaluation to confirm the diagnosis and rule out malignant otitis externa, cholesteatoma, or tumor
• Patients with active fungal or bacterial infection (need targeted topical therapy)
• Diabetic or immunocompromised patients with otitis externa (high risk of skull-base osteomyelitis)
• Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
• People with hemophilia or any other inherited bleeding disorder
• Patients with severe anemia (hemoglobin under 10 g/dL)
• People with an active infection at the planned application site

What to ask your clinician

• Has ENT evaluated my ear canal and ruled out malignant otitis externa or other serious causes?
• Have appropriate topical antibiotic, antifungal, or steroid drops been tried?
• Have aural toileting and trigger avoidance been addressed?
• What is the published evidence base for leeches in otitis externa?
• Where exactly will leeches be placed, and how is proximity to the ear canal managed?
• How will worsening infection be detected during the course?

When to seek urgent care

• Bleeding from a bite site that soaks through more than one dressing per hour
• Bleeding that continues more than 24 hours after the leech detached
• Spreading redness, warmth, swelling, pus, or red streaks around any bite site
• Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
• Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
• Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
• Severe ear pain disproportionate to physical findings (possible malignant otitis externa, especially in diabetics)
• Facial weakness, severe headache, or fever (could indicate skull-base osteomyelitis)
• New hearing loss, vertigo, or persistent discharge